# Oncolytics Biotech Inc. (ONCY): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/oncy for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metastatic breast cancer, metastatic pancreatic ductal adenocarcinoma, and anal cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was...

## Quote & Key Metrics

As of 2026-10-30:

| Metric | Value |
|---|---|
| Price | $0.43 USD |
| Market Cap | $42.7M |
| P/E (TTM) | — |
| EPS (TTM) | −$0.27 |
| 52-Week Range | $0.41 – $1.30 |
| Dividend Yield (TTM) | — |

## Dividend

ONCY has no dividend payment history in our records.

## Frequently Asked Questions

### What does Oncolytics Biotech Inc. do?

Oncolytics Biotech Inc. (ONCY) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is ONCY's market cap?

Oncolytics Biotech Inc. (ONCY) has a market capitalization of approximately $42.7 million, as of October 30, 2026, based on the most recent share price and shares outstanding.

### Does ONCY pay a dividend?

No, Oncolytics Biotech Inc. (ONCY) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is ONCY profitable?

Oncolytics Biotech Inc. (ONCY) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has ONCY ever paid a dividend?

No. Dividend Data's records show no dividend payments from Oncolytics Biotech Inc. (ONCY). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/oncy
- Dividend history & safety: https://www.dividenddata.com/stocks/oncy/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/oncy/earnings
- Financial statements: https://www.dividenddata.com/stocks/oncy/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/oncy/valuation
- Peer comparison: https://www.dividenddata.com/stocks/oncy/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.